Jon Seiders

Jon Seiders is the VP CMC at Pipeline Therapeutics since April 2019. Jon previously held the position of Director of Chemistry at Inception Sciences from February 2013 to April 2019. Prior to that, Jon was an Executive Director at Bristol-Myers Squibb from September 2011 to September 2012, and a Senior Director at Amira Pharmaceuticals from September 2005 to September 2011. Jon also worked as a Research Fellow at Merck from September 2001 to July 2005. Jon holds a Post Doc degree in Organic Chemistry from Caltech, a Ph.D. in Organic Chemistry from UC San Diego, and a B.S. in Chemistry from San Diego State University.